These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5755257)

  • 1. [Therapeutic effect of heterologous antihuma lymphocyte serum (AHLS) in chronic lympahtic leukemia].
    Tsirimbas AD; Pichlmayr R; Hornung B; Pfisterer H; Thierfelder S; Brendel W; Stich W
    Klin Wochenschr; 1968 Jun; 46(11):583-6. PubMed ID: 5755257
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lymphopenia caused by antilymphocyte serum in chronic lymphatic leukemia].
    Pfisterer H; Michlmayr G; Meinzel E; Bolland H; Tsirimbas AD; Hornung B; Ruppelt W; Stich W
    Dtsch Med Wochenschr; 1968 Nov; 93(45):2159-61. PubMed ID: 5683957
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of chronic lymphatic leukemia with heterologous antilymphocytic serum. I. Obtaining of heterologous serum against lymphocytes of chronic lymphatic leukemia].
    Jasser S; Pawelski S; Skowrońska H; Tupalska B; Brühlowa A
    Acta Haematol Pol; 1971; 2(1):17-25. PubMed ID: 5170673
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of heterologous antilymphocyte globulin in chronic lymphoid leukemia].
    Pfisterer H; Lani K; Demmler K; Thierfelder S; Fateh-Moghadam A; Land W; Brendel W; Stich W
    Dtsch Med Wochenschr; 1971 Sep; 96(37):1468 passim. PubMed ID: 5105950
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chronic lymphatic leukemia: disorders of lymphocyte kinetics. Pathophysiological aspects and therapeutic consideration].
    Bremer K
    Dtsch Med Wochenschr; 1975 May; 100(22):1250-5. PubMed ID: 1132340
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with heterologous antilymphocyte serums in man].
    Pichlmayr R; Brendel W; Zenker R
    Munch Med Wochenschr; 1968 Apr; 110(15):893-8. PubMed ID: 4892058
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunotherapy of leukemia--a realistic clinical possibility?].
    Gahrton G
    Lakartidningen; 1971 Mar; 68(14):1601-8. PubMed ID: 4930453
    [No Abstract]   [Full Text] [Related]  

  • 8. Antithymocyte antisera globulin effect on human lymphoid neoplasia.
    Pirofsky B; Beaulieu R; Goldman RD
    Arch Intern Med; 1973 Aug; 132(2):171-4. PubMed ID: 4198179
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytolytic effects of alloantiserum in patients with lymphoproliferative disorders.
    Herberman RB; Oren ME; Rogentine GN; Fahey JL
    Cancer; 1971 Aug; 28(2):365-71. PubMed ID: 5566358
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fine structure of circulating lymphocytes under the effect of antilymphocyte serum (ALS) in chronic lymphatic leukemia].
    Hu D; Pfisterer H; Lani K
    Blut; 1970 May; 20(5):273-81. PubMed ID: 4986661
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serologic studies of patients under treatment with xenogenous antilymphocyte globulin].
    Hopf U; Fateh-Moghadam A; Land W; Brendel W
    Klin Wochenschr; 1970 Aug; 48(15):906-13. PubMed ID: 4996980
    [No Abstract]   [Full Text] [Related]  

  • 12. [In vivo behavior of lymphocytes in patients with chronic lymphadenosis under the effect of anti-lymphadenosis gamma globulin].
    Preussner S; Frick G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(2):183-95. PubMed ID: 4136381
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic myelocytic and chronic lymphocytic leukemia.
    Huguley CM
    Cancer; 1972 Dec; 30(6):1583-7. PubMed ID: 4509107
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone-marrow toxicity of methotrexate: a reassessment.
    Douglas ID; Price LA
    Br J Haematol; 1973 May; 24(5):625-31. PubMed ID: 4514552
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative study of the peripheral lymphocyte count in controls and in patients with chronic lymphocytic leukemias 4 hours after injection of hydrocortisone (author's transl)].
    Dighiero G; Charron D; Vaugier G; Leporrier M; Debré P; d'Athis P; Binet JL
    Nouv Rev Fr Hematol (1978); 1978 Jun; 20(2):317-22. PubMed ID: 309108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Induction of tolerance of heterologous protein in therapy with antilymphocytic globulin in man].
    Tilz GP
    Med Klin; 1972 Mar; 67(12):410-3. PubMed ID: 4112374
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies with heterologous antilymphocytic serum as a therapy for chronic lymphocytic leukemia.
    Tsirimbas AD; Pfisterer H; Hornung B; Thierfelder S; Michlmayr G; Stich W
    Blut; 1969 Oct; 19(7):420-3. PubMed ID: 5260739
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antilymphocyte immunoglobulin with an associated antibacterial directed effect. II. The use of the preparation in the overall therapy of chronic lympholeukemia].
    Shabalin VN; Abdulkadyrov KM; Serova LD; Smirnova AI; Samuskevich IG
    Zh Mikrobiol Epidemiol Immunobiol; 1979 May; (5):26-30. PubMed ID: 377863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-inflammatory effect of heterologous anti-polymorphonuclear leucocyte serum on adjuvant-induced arthritis.
    Zuccarello WA; Wolff CE; Walz DT
    Proc Soc Exp Biol Med; 1974 Mar; 145(3):1042-6. PubMed ID: 4406160
    [No Abstract]   [Full Text] [Related]  

  • 20. The influencing of the systemic hypersensitivity fever reaction with antilymphocyte and antipolymorphonuclear sera.
    Castrová A; Pekárek J; Johanovský J
    Z Immunitatsforsch Exp Klin Immunol; 1971 Apr; 141(4):332-43. PubMed ID: 4252950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.